Anika Therapeutics Inc (ANIK)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Anika Therapeutics Inc-Aktie (ANIK)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.70% 40.52	42.97	41.47	44.30	37.92
Cost Of Revenue	4.49% 15.89	16.64	16.52	15.33	15.08
Gross Profit	6.46% 24.63	26.33	24.94	28.97	22.84
Operating Expenses	67.05% 29.69	90.11	32.62	32.60	35.40
Benefits Costs and Expenses	57.62% 44.99	106.17	48.50	47.37	49.94
Costs And Expenses	67.05% 29.69	90.11	32.62	32.60	35.40
Depreciation and Amortization	6.51% 1.734	1.628	1.596	1.605	1.605
Operating Income/Loss	92.06% -5.063	-63.78	-7.674	-3.631	-12.55
Income/Loss From Continuing Operations Before Tax	92.93% -4.471	-63.20	-7.039	-3.07	-12.01
Income Tax Expense/Benefit, Deferred	110.47% 0.193	-1.843	-1.207	-0.904	-2.373
Income Tax Expense/Benefit	121.08% 0.043	-0.204	-0.463	-0.329	-1.664
Income/Loss From Continuing Operations After Tax	92.83% -4.514	-63.00	-6.576	-2.741	-10.35
Net Income/Loss	92.83% -4.514	-63.00	-6.576	-2.741	-10.35
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	490.03K% 14.70	-0.003	14.63	14.69	14.65
Diluted Average Shares	490.03K% 14.70	-0.003	14.63	14.69	14.65
Basic Earnings Per Share	92.79% -0.31	-4.30	-0.45	-0.19	-0.71
Diluted Earnings Per Share	92.79% -0.31	-4.30	-0.45	-0.19	-0.71
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$11.63

1.61%

LNTH

$89.28

2.89%

ITCI

$83.45

0.82%

RDY

$15.37

1.65%

NBIX

$135.42

0.34%

VTRS

$12.52

3.22%